ConductScience.org, home

Paper36738367

An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development.

Upadhayay S and 11 others. Neurochem Res, 2023. Cited by 29 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development. Papers, record 36738367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36738367

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development.
PubMed
Journal
Neurochem Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
4.02
iCite
Revised in PubMed
2026-10-30
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Upadhayay SShubham
2Yedke NGNarhari Gangaram
3Rahi VVikrant
4Singh SSurbhi
5Kumar SSachin
6Arora AAnchal
7Chandolia PPriyanka
8Kaur PPrabhsharan
9Kumar MMandeep
10Koshal PPrashant
11Jamwal SSumit
12Kumar PPuneet

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Huntington DiseaseMajor topic
Animals
Neurotoxins
Disease Models, Animal
Nitro Compounds
Propionates
Drug Discovery

Source PubMed

References160

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126,833,174Hippocampal dysfunction defines disease onset in Huntington's disease.J Neurol Neurosurg Psychiatry2016https://conductscience.org/library/papers/26833174PubMed
217,572,452Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.Physiol Behav2007https://conductscience.org/library/papers/17572452PubMed
322,154,757Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity.Eur J Pharmacol2012https://conductscience.org/library/papers/22154757PubMed
48,593,585Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease.Brain Res1995https://conductscience.org/library/papers/8593585PubMed
58,837,046Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity.Neurochem Int1996https://conductscience.org/library/papers/8837046PubMed
632,796,930Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.Nat Rev Neurol2020https://conductscience.org/library/papers/32796930PubMed
730,054,774
Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.
Metab Brain Dis2018https://conductscience.org/library/papers/30054774PubMed
830,260,985Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.PLoS One2018https://conductscience.org/library/papers/30260985PubMed
93,629Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.J Neurochem1976https://conductscience.org/library/papers/3629PubMed
1018,093,658Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.Neurotoxicology2008https://conductscience.org/library/papers/18093658PubMed
1127,011,624The story of George Huntington and his disease.Ann Indian Acad Neurol2016https://conductscience.org/library/papers/27011624PubMed
127,629,905Moldy sugarcane poisoning--a case report with a brief review.J Toxicol Clin Toxicol1995https://conductscience.org/library/papers/7629905PubMed
1319,927,170Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status.Neurosci Bull2009https://conductscience.org/library/papers/19927170PubMed
1419,627,208
Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
J Med Food2009https://conductscience.org/library/papers/19627208PubMed
159,875,735Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats.Neuroreport1998https://conductscience.org/library/papers/9875735PubMed
161,851,219Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus.J Neurosci1991https://conductscience.org/library/papers/1851219PubMed
1717,007,735Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.Acta Pharmacol Sin2006https://conductscience.org/library/papers/17007735PubMed
1830,021,362Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.Biomed Pharmacother2018https://conductscience.org/library/papers/30021362PubMed
1922,515,819Optimal dosages of fluoxetine in the treatment of hypoxic brain injury induced by 3-nitropropionic acid: implications for the adjunctive treatment of patients after acute ischemic stroke.CNS Neurosci Ther2012https://conductscience.org/library/papers/22515819PubMed
2019,504,387Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats.J Asian Nat Prod Res2009https://conductscience.org/library/papers/19504387PubMed

See all 160 references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
42,616,200The potential of vitamins in Huntington's disease: bridging mechanistic evidence with translational limitations and future strategies.Metab Brain Dis2026https://conductscience.org/library/papers/42616200PubMed
42,217,1093-Nitropropionic Acid-Induced Huntington's Disease in Preclinical Models: Mechanisms, Peripheral Toxicities, Model Gaps, and Future Directions.Mol Neurobiol2026https://conductscience.org/library/papers/42217109PubMed
42,213,222Neuroprotective Potential of Pinostrobin in a Rat Model of Huntington's Disease: Behavioural, Biochemical, and Molecular Docking Evidence.Mol Neurobiol2026https://conductscience.org/library/papers/42213222PubMed
41,870,813Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches.Mol Neurobiol2026https://conductscience.org/library/papers/41870813PubMed
41,762,337
Roflumilast Elicits Therapeutic and Neuroprotective Effects in 3-Nitropropionic Acid-Induced Huntington's Disease-Like Neurodegeneration in Rats by Mitigating NLRP3 Inflammasome-Mediated Pyroptosis, Ferroptosis, and Glial Activation.
Neurochem Res2026https://conductscience.org/library/papers/41762337PubMed
41,276,654Anandamide-Induced Neuroprotection of Cortical Neurons Relies on Metabolic/Redox Regulation and Mitochondrial Dynamics.Mol Neurobiol2025https://conductscience.org/library/papers/41276654PubMed
41,255,420A design-of-experiments strategy for engineering 3D topographical features in osteosarcoma modelling.Mater Today Bio2025https://conductscience.org/library/papers/41255420PubMed
40,956,543Neuroprotective effects of candesartan in 3-nitropropionic acid-induced Huntington's disease: modulation of angiotensin and CREB/BDNF/PGC1-α signaling.Inflammopharmacology2025https://conductscience.org/library/papers/40956543PubMed
40,867,512Progress on 3-Nitropropionic Acid Derivatives.Biomolecules2025https://conductscience.org/library/papers/40867512PubMed
40,314,217The role of gut microbiota-mitochondria crosstalk in neurodegeneration: Underlying mechanisms and potential therapies.Neural Regen Res2026https://conductscience.org/library/papers/40314217PubMed
40,252,127
Oxytocin Anti-Apoptotic Potential Mediates Neuroprotection Against 3-Nitropropionic Acid-Induced Huntington's Disease-Like Pathophysiology in Rats: Involvement of Calpain-2/p25 Cdk5/MEF-2 Signaling Pathway.
Neurochem Res2025https://conductscience.org/library/papers/40252127PubMed
39,820,855Neuroinflammation and neurodegeneration in Huntington's disease: genetic hallmarks, role of metals and organophosphates.Neurogenetics2025https://conductscience.org/library/papers/39820855PubMed
39,764,462A supercritical oil extract of Schisandra chinensis seeds ameliorates Huntington's disease-like symptoms and neuropathology: the potential role of anti-oxidant and anti-inflammatory effects.Front Pharmacol2024https://conductscience.org/library/papers/39764462PubMed
39,546,221Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases.Inflammopharmacology2025https://conductscience.org/library/papers/39546221PubMed
39,414,701Glycosylation of chrysin with β-d-glucose tetraacetate (LQFM280) enhances its in vitro and in vivo neuroprotective effects against the toxicity induced by 3-nitropropionic acid.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39414701PubMed
38,982,016Mitochondrial targeted antioxidants as potential therapy for huntington's disease.Pharmacol Rep2024https://conductscience.org/library/papers/38982016PubMed
38,427,225TUNEL-n-DIFL Method for Detection and Estimation of Apoptosis Specifically in Neurons and Glial Cells in Mixed Culture and Animal Models of Central Nervous System Diseases and Injuries.Methods Mol Biol2024https://conductscience.org/library/papers/38427225PubMed
38,372,755Neuroprotective effects of levothyroxine on cognition deficits and memory in an experimental model of Huntington's disease in rats: An electrophysiological study.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/38372755PubMed
38,306,038Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.J Alzheimers Dis2024https://conductscience.org/library/papers/38306038PubMed
37,875,411[Research advances of porous organic framework materials on enrichment and detection of mycotoxins].Se Pu2023https://conductscience.org/library/papers/37875411PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36738367

GET https://conductscience.org/api/papers/v1/36738367/references?page=2